SpyGlass Ophthalmics snags $27.5m Series B
SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing.
SpyGlass Ophthalmics, an ophthalmic therapeutics company, has secured $27.5 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination